Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy M&G (MNG) by Christopher Ruane in The Motley Fool
- Buy Serco Group (SRP) by Ben McPoland in The Motley Fool
- Buy Lloyds Banking Group (LLOY) by Christopher Ruane in The Motley Fool
- Buy Legal & General Group (LGEN) by Christopher Ruane in The Motley Fool
- Buy Hargreaves Lansdown (HL.) by Oliver Rodzianko in The Motley Fool
- Buy Wetherspoon (J.D.) (JDW) by Christopher Ruane in The Motley Fool
- Buy Rightmove (RMV) by UBS
- Buy Prudential (PRU) by UBS
- Neutral Pearson (PSON) by Exane
- Buy Renew Holdings (RNWH) by Berenberg
- Hold Frontier Developments (FDEV) by Berenberg
- Long Term Buy Phoenix Group Holdings (PHNX) by Simon Watkins in The Motley Fool
- Long Term Buy M&G (MNG) by Simon Watkins in The Motley Fool
- Long Term Buy Legal & General Group (LGEN) by Simon Watkins in The Motley Fool
- Buy British Land Company (BLND) by Peel Hunt
- Buy Hochschild Mining (HOC) by Peel Hunt
- Buy Sirius Real Estate Ltd. (SRE) by HSBC
- Buy Coats Group (COA) by HSBC
- Buy Melrose Industries (MRO) by Citi
- Equal Weight NATWEST GROUP (NWG) by Morgan Stanley
Valirx (VAL) Share Price
Health Care Sector
NOTE: This is based on 6 open tips for Valirx (VAL)
| Latest Bid : 10.00p | Latest Ask : 11.00p |
| High Today : 11.00p | Low Today : 10.15p |
| This Years High : 17.50p | This Years Low : 5.40p |
| Volume : 99,421 | MKT Cap : £11.22M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Valirx (VAL) Overview
ValiRx accelerates the development of treatments in cancer and women's health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Valirx (VAL) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Tom Winnifrith | Premium Only | 2020-06-02 11:40:00 02/06/2020 | -11.45% |
| Sell | Nigel Somerville | Premium Only | 2020-04-02 11:45:00 02/04/2020 | -26,775.00% |
| Buy | Align Research Team | Premium Only | 2018-10-24 09:45:00 24/10/2018 | -73.13% |
| Sell | Nigel Somerville | Premium Only | 2016-04-02 11:00:00 02/04/2016 | 92.22% |
| Sell | Tom Winnifrith | Premium Only | 2015-09-17 15:14:45 17/09/2015 | 93.02% |
Valirx (VAL) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 10.00p | Latest Ask : 11.00p |
| High Today : 11.00p | Low Today : 10.15p |
| This Years High : 17.50p | This Years Low : 5.40p |
| Volume : 99,421 | MKT Cap : £11.22M |
Valirx Overview
ValiRx accelerates the development of treatments in cancer and women's health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Valirx Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Tom Winnifrith | Premium Only | 2020-06-02 11:40:00 02/06/2020 | -11.45% |
| Sell | Nigel Somerville | Premium Only | 2020-04-02 11:45:00 02/04/2020 | -26,775.00% |
| Buy | Align Research Team | Premium Only | 2018-10-24 09:45:00 24/10/2018 | -73.13% |
| Sell | Nigel Somerville | Premium Only | 2016-04-02 11:00:00 02/04/2016 | 92.22% |
| Sell | Tom Winnifrith | Premium Only | 2015-09-17 15:14:45 17/09/2015 | 93.02% |